Mathieu C, Rudofsky G, Phillip M, Araki E, et al. Long-term efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (the DEPICT-2 study): 52-week results from a randomized controlled trial. Diabetes Obes Metab 2020 Apr 20. doi: 10.1111/dom.14060.
PMID: 32311204